Skip to Main Content
American Flag
MEMORIAL DAY API SALE

50% off your first year of Quiver API

...

Use Promo Code:

MEM50
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Press Release: Castor, Fitzpatrick, and Underwood Reintroduce Bipartisan Legislation to Include Pregnant and Lactating Women in Clinical Research

None

Representatives reintroduce bipartisan legislation to enhance clinical research on pregnant and lactating women for health safety.

Quiver AI Summary

Legislation Reintroduced: Representatives Kathy Castor, Brian Fitzpatrick, and Lauren Underwood have reintroduced bipartisan legislation known as H.R. 8651, the Advancing Safe Medications for Moms and Babies Act. The aim is to increase the inclusion of pregnant and lactating women in clinical research regarding medication safety.

Support and Objectives: The legislation seeks to modernize FDA regulations, raise awareness of the importance of this research, and encourage priority studies at the NIH. The representatives emphasize the need for accurate guidance concerning the effects of medications on both mothers and infants.

Community Response: Various health organizations, including ACOG and March of Dimes, support the initiative, citing the necessity for better data on medication effects during pregnancy. “Excluding pregnant and lactating individuals from clinical trials creates significant information gaps,” stated Rep. Castor.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

🏛️ Receive Alerts on Congress
Sign Up

Kathy Castor Fundraising

Kathy Castor Fundraising

Kathy Castor recently disclosed $213.3K of fundraising in a Q1 FEC disclosure filed on April 15th, 2026. This was the 520th most from all Q1 reports we have seen this year. 45.8% came from individual donors.

Castor disclosed $80.3K of spending. This was the 921st most from all Q1 reports we have seen from politicians so far this year.

Castor disclosed $716.6K of cash on hand at the end of the filing period. This was the 518th most from all Q1 reports we have seen this year.

You can see the disclosure here, or track Kathy Castor's fundraising on Quiver Quantitative.

Kathy Castor Net Worth

Quiver Quantitative estimates that Kathy Castor is worth $15.4M, as of May 7th, 2026. This is the 85th highest net worth in Congress, per our live estimates.

Castor has approximately $3.6M invested in publicly traded assets which Quiver is able to track live.

You can track Kathy Castor's net worth on Quiver Quantitative's politician page for Castor.

Kathy Castor Bill Proposals

Here are some bills which have recently been proposed by Kathy Castor:

  • H.R.8651: Advancing Safe Medications for Moms and Babies Act of 2026
  • H.R.7305: Energy Threat Analysis Center Act of 2026
  • H.R.6620: To amend the National Flood Insurance Act of 1968 to allow for the consideration of private flood insurance for the purposes of applying continuous coverage requirements, and for other purposes.
  • H.R.6561: PREVENT HPV Cancers Act of 2025
  • H.R.6178: Increasing Access to Lung Cancer Screening Act
  • H.R.6080: CLEANER Act of 2025

You can track bills proposed by Kathy Castor on Quiver Quantitative's politician page for Castor.

2026 Florida's 14th Congressional District Election

There has been approximately $1,657,876 of spending in Florida's 14th congressional district elections over the last two years, per our estimates.

The rating for this race is currently "Solid D".

You can track this election on our matchup page for the 2026 Florida's 14th congressional district election.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles